Gain Therapeutics (GANX) Stock Chart & Stock Price History → Millionaire Investor makes surprising election prediction (From InvestorPlace) (Ad) Free GANX Stock Alerts $2.63 -0.06 (-2.23%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Gain Therapeutics Stock Price Performance5 Day Performance+8.68%1 Month Performance-16.51%3 Month Performance-45.44%6 Month Performance-2.59%Year-To-Date Performance-19.45%1 Year Performance-44.98% Receive GANX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. GANX Stock Chart for Saturday, May, 18, 2024 GANX Chart by TradingView Gain Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.69$2.63-2.23%$2.80$2.5359,244 shs$47.47 million05/16/2024$2.62$2.69+2.67%$2.83$2.58128,634 shs$48.56 million05/15/2024$2.34$2.62+11.97%$2.65$2.40145,726 shs$47.29 million05/14/2024$2.42$2.34-3.31%$2.58$2.34240,358 shs$42.24 million05/13/2024$2.51$2.42-3.59%$2.59$2.3654,674 shs$43.68 million05/10/2024$2.54$2.51-1.18%$2.70$2.41106,802 shs$45.31 million Get the Latest News and Ratings for GANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.68$2.54-5.22%$2.97$2.48239,414 shs$45.85 million05/08/2024$2.90$2.68-7.59%$2.98$2.65202,493 shs$48.37 million05/07/2024$2.85$2.90+1.75%$3.14$2.78164,577 shs$52.35 million05/06/2024$2.96$2.85-3.72%$3.03$2.82131,742 shs$51.45 million05/03/2024$2.93$2.96+1.02%$3.02$2.8794,947 shs$53.43 million05/02/2024$2.97$2.93-1.35%$3.06$2.87121,216 shs$52.89 million05/01/2024$2.93$2.97+1.37%$3.05$2.9257,798 shs$53.61 million04/30/2024$3.00$2.93-2.33%$3.00$2.8934,753 shs$47.53 million04/29/2024$3.03$3.00-0.99%$3.03$2.8938,570 shs$48.66 million04/26/2024$3.07$3.03-1.30%$3.18$2.89179,297 shs$49.15 million04/25/2024$3.19$3.07-3.76%$3.20$2.95142,396 shs$49.80 million04/24/2024$3.39$3.19-5.90%$3.65$3.12146,812 shs$51.74 million04/23/2024$3.17$3.39+6.94%$3.39$3.0766,419 shs$54.99 million04/22/2024$3.18$3.17-0.31%$3.43$3.1253,675 shs$51.42 million04/19/2024$3.15$3.18+0.95%$3.23$3.0071,353 shs$51.58 million04/18/2024$3.18$3.15-0.94%$3.31$3.1178,261 shs$51.09 million04/17/2024$3.16$3.18+0.63%$3.27$3.1080,646 shs$51.58 million04/16/2024$3.09$3.16+2.27%$3.19$2.93111,460 shs$51.26 million04/15/2024$3.15$3.09-1.90%$3.23$3.0281,897 shs$50.12 million04/12/2024$3.36$3.15-6.25%$3.32$3.01123,743 shs$51.09 million04/11/2024$3.34$3.36+0.60%$3.41$3.2547,249 shs$54.50 million04/10/2024$3.38$3.34-1.18%$3.38$3.1079,471 shs$54.18 million04/09/2024$3.43$3.38-1.46%$3.53$3.3063,783 shs$54.82 million04/08/2024$3.56$3.43-3.65%$3.64$3.3175,270 shs$55.64 million04/05/2024$3.58$3.56-0.56%$3.72$3.49105,241 shs$57.74 million04/04/2024$3.99$3.58-10.28%$4.04$3.45177,370 shs$58.07 million04/03/2024$3.89$3.99+2.57%$4.04$3.7458,129 shs$64.72 million04/02/2024$3.83$3.89+1.57%$4.00$3.8292,050 shs$63.10 million04/01/2024$3.77$3.83+1.59%$4.00$3.57122,238 shs$62.12 million03/29/2024$3.77$3.77$3.95$3.68102,217 shs$61.15 million03/28/2024$3.73$3.77+1.07%$3.95$3.68102,211 shs$48.67 million03/27/2024$3.80$3.73-1.84%$3.90$3.60114,019 shs$48.15 million03/26/2024$3.65$3.80+4.11%$3.96$3.57145,671 shs$49.06 million03/25/2024$4.06$3.65-10.10%$4.10$3.55209,466 shs$47.12 millionget a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024.03/22/2024$4.37$4.06-7.09%$4.45$3.80246,566 shs$52.42 million03/21/2024$4.26$4.37+2.58%$4.63$4.21214,879 shs$56.42 million03/20/2024$4.25$4.26+0.24%$4.35$4.0978,321 shs$55.00 million03/19/2024$4.36$4.25-2.52%$4.38$4.2044,212 shs$54.87 million03/18/2024$4.29$4.36+1.63%$4.50$4.2570,799 shs$56.29 million03/15/2024$4.28$4.29+0.23%$4.43$4.22183,270 shs$55.38 million03/14/2024$4.54$4.28-5.73%$4.56$4.20145,820 shs$55.26 million03/13/2024$4.56$4.54-0.44%$4.65$4.3958,829 shs$58.61 million03/12/2024$4.67$4.56-2.36%$4.74$4.39104,016 shs$58.87 million03/11/2024$4.73$4.67-1.27%$4.74$4.6526,441 shs$60.29 million03/08/2024$4.60$4.73+2.83%$4.80$4.6444,774 shs$61.06 million03/07/2024$4.71$4.60-2.34%$4.75$4.5876,807 shs$59.39 million03/06/2024$4.66$4.71+1.07%$4.78$4.6069,784 shs$60.81 million03/05/2024$4.72$4.66-1.27%$4.79$4.17696,713 shs$60.16 million03/04/2024$4.68$4.72+0.85%$5.18$4.70348,173 shs$60.94 million03/01/2024$4.49$4.68+4.23%$4.70$4.52103,235 shs$60.42 million02/29/2024$4.46$4.49+0.67%$4.62$4.4462,893 shs$57.97 million02/28/2024$4.63$4.46-3.67%$4.80$4.4671,124 shs$57.58 million02/27/2024$4.50$4.63+2.89%$4.70$4.40104,662 shs$59.77 million02/26/2024$4.55$4.50-1.10%$4.75$4.4265,802 shs$58.10 million02/23/2024$4.44$4.55+2.48%$4.64$4.3661,302 shs$58.74 million02/22/2024$4.42$4.44+0.45%$4.50$4.10196,120 shs$57.32 million02/21/2024$4.67$4.42-5.35%$4.75$4.39128,219 shs$57.06 million02/20/2024$4.82$4.67-3.11%$4.89$4.6680,162 shs$60.29 million02/19/2024$4.82$4.82$4.92$4.6298,000 shs$62.23 million Related Companies: Eyenovia Stock Price Chart CASI Pharmaceuticals Stock Price Chart VYNE Therapeutics Stock Price Chart Unicycive Therapeutics Stock Price Chart HCW Biologics Stock Price Chart Ocuphire Pharma Stock Price Chart Xilio Therapeutics Stock Price Chart NextCure Stock Price Chart Lexaria Bioscience Stock Price Chart Cara Therapeutics Stock Price Chart Receive GANX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gain Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GANX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gain Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.